Fuxiang Pharmaceutical Chairman Bao Jianhua Detained by Supervisory Authority

The significance here lies less in the detention itself than in the concentration of roles: Bao is simultaneously controlling shareholder, actual controller and chairman, so the company's ownership and governance rest on one person now under supervisory authority control. The filing offers no details, which leaves the scope — whether it touches the listed entity or only Bao personally — unresolved. What matters next is whether Fuxiang discloses any change in control, board authority or operating impact, and whether the supervisory action expands beyond the individual.